These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32266586)

  • 1. Significance of HPV16 Viral Load Testing in Anal Cancer.
    Małusecka E; Chmielik E; Suwiński R; Giglok M; Lange D; Rutkowski T; Mazurek AM
    Pathol Oncol Res; 2020 Oct; 26(4):2191-2199. PubMed ID: 32266586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
    Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
    Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma.
    Valmary-Degano S; Jacquin E; Prétet JL; Monnien F; Girardo B; Arbez-Gindre F; Joly M; Bosset JF; Kantelip B; Mougin C
    Hum Pathol; 2013 Jun; 44(6):992-1002. PubMed ID: 23266444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16.
    Biesaga B; Mucha-Małecka A; Janecka-Widła A; Kołodziej-Rzepa M; Szostek S; Słonina D; Kowalczyk A; Halaszka K; Przewoźnik M
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):63-73. PubMed ID: 29043437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.
    Alemany L; Saunier M; Alvarado-Cabrero I; Quirós B; Salmeron J; Shin HR; Pirog EC; Guimerà N; Hernandez-Suarez G; Felix A; Clavero O; Lloveras B; Kasamatsu E; Goodman MT; Hernandez BY; Laco J; Tinoco L; Geraets DT; Lynch CF; Mandys V; Poljak M; Jach R; Verge J; Clavel C; Ndiaye C; Klaustermeier J; Cubilla A; Castellsagué X; Bravo IG; Pawlita M; Quint WG; Muñoz N; Bosch FX; de Sanjosé S;
    Int J Cancer; 2015 Jan; 136(1):98-107. PubMed ID: 24817381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.
    Meyer JE; Panico VJ; Marconato HM; Sherr DL; Christos P; Pirog EC
    J Gastrointest Cancer; 2013 Dec; 44(4):450-5. PubMed ID: 24014082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of HPV status and p16 expression in patients with carcinoma of the anal canal.
    Roldán Urgoiti GB; Gustafson K; Klimowicz AC; Petrillo SK; Magliocco AM; Doll CM
    PLoS One; 2014; 9(10):e108790. PubMed ID: 25271758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
    Holzinger D; Flechtenmacher C; Henfling N; Kaden I; Grabe N; Lahrmann B; Schmitt M; Hess J; Pawlita M; Bosch FX
    Int J Cancer; 2013 Sep; 133(6):1389-99. PubMed ID: 23457055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.
    Sundström K; Ploner A; Dahlström LA; Palmgren J; Dillner J; Adami HO; Ylitalo N; Sparén P
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):150-8. PubMed ID: 23155137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.
    Pouwer AW; Te Grootenhuis NC; Hinten F; de Bock GH; van der Zee AGJ; Melchers WJG; Oonk MHM; de Hullu JA; Hollema H; Bulten J
    Virchows Arch; 2024 Jun; 484(6):985-994. PubMed ID: 37938322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.
    Evans MF; Matthews A; Kandil D; Adamson CS; Trotman WE; Cooper K
    Head Neck Pathol; 2011 Dec; 5(4):344-8. PubMed ID: 21786153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
    Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and p16
    Mohanty SK; Mishra SK; Bhardwaj N; Sardana R; Jaiswal S; Pattnaik N; Pradhan D; Sharma S; Kaushal S; Baisakh MR; Das S; Pradhan MR; Satapathy K; Pattnaik A; Sharma SK; Khadenga CR; Das S; Rath D; Nanda B; Parwani AV
    Clin Genitourin Cancer; 2021 Dec; 19(6):510-520. PubMed ID: 34348854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma.
    Halec G; Holzinger D; Schmitt M; Flechtenmacher C; Dyckhoff G; Lloveras B; Höfler D; Bosch FX; Pawlita M
    Br J Cancer; 2013 Jul; 109(1):172-83. PubMed ID: 23778529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
    Kreuter A; Wieland U; Gambichler T; Altmeyer P; Pfister H; Tenner-Racz K; Racz P; Potthoff A; Brockmeyer NH;
    Br J Dermatol; 2007 Sep; 157(3):523-30. PubMed ID: 17573882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.